Author(s):
R. Nagaraju, P. Subhash Chandra Bose, G. Ravi, Damineni Saritha, Valluru Ravi
Email(s):
penjurisubhash@gmail.com
DOI:
Not Available
Address:
R. Nagaraju1, P. Subhash Chandra Bose2*, G. Ravi2, Damineni Saritha3, Valluru Ravi2
1Department of Pharmaceutics, Sri Padmavati Mahila Visvavidyalayam, Tirupati-517502, Andhra Pradesh, India.
2Department of Pharmaceutics, MNR College of Pharmacy, Sangareddy-502294, Telangana State, India.
3Department of Pharmaceutics, Sultan-ul-Uloom College of Pharmacy, Hyderabad-500034, T.S., India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 6,
Year - 2020
ABSTRACT:
The main purpose of the present review is to compile the recent literature with special focus on different aspects of Buccal drug delivery system (BDDS) that achieve significance place among novel drug deliveries. The main obstacles that drugs meet when administered via the buccal route derive from the limited absorption area and the barrier properties of the mucosa. The successful physiological removal mechanisms of the oral cavity that take the formulation away from the absorption site are the other obstacles that have to be considered. In this regard, this present review covers the areas of anatomy and nature of oral cavity mechanisms and theories of bioadhesion, mucoahesion, factors affecting the bio/mucoadhesive devices, in vitro and in vivo evaluation of novel buccal drug delivery systems, limitations of buccal drug administration.
Cite this article:
R. Nagaraju, P. Subhash Chandra Bose, G. Ravi, Damineni Saritha, Valluru Ravi. A Review on Current status of Buccal drug delivery system. Research J. Pharm. and Tech 2020; 13(6): 2954-2962.
Cite(Electronic):
R. Nagaraju, P. Subhash Chandra Bose, G. Ravi, Damineni Saritha, Valluru Ravi. A Review on Current status of Buccal drug delivery system. Research J. Pharm. and Tech 2020; 13(6): 2954-2962. Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-6-76
REFERENCES:
1. Chien Y. W, Oral drug delivery and delivery systems In: Chien Y. W., ed. Novel drug delivery systems. Marcel Dekker, New York, 1992, PP 139-96.
2. Prescott L. F, The need for improved drug delivery in clinical practice. In: Prescott L. F, Nimmo W. S., ed. Novel drug delivery. John Wiley and Sons Ltd, West Sussex, England, 1988, PP 1-11.
3. Rowland M, Tozer T. N, Absorption. In: Rowland M, Tozer T. N., ed. Clinical pharmacokinetics. 2nd edition, Lea and Febiger, Malvern, P. A, 1989, PP 113-30.
4. John D Smart, Buccal drug delivery, Expert Opin Drug Deliv., 2, 2005, PP 507-517.
5. N. V. Satheesh Madhav, Ashok K. Shakya, Pragati Shakya, Kuldeep Singh, Orotransmucosal drug delivery systems: A review, J Control Release, 140, 2009, PP 2-11.
6. Hernandez R. M, Gascon A. R, Calvo M. B, Caramella C, Conte U, Domniquez-Gil A, Pedraz J. L, Influence of route of administration and dosage form in the pharmacokinetics and bioavailability of salbutamol, Eur J Drug Metab Pharmacokinet., 22, 1997, 145-150.
7. Kyles A. E, Papich M, Hardie E. M, Disposition of transdermally administered fentanyl in dogs, Am J Vet Res., 57, 1996, PP 715-719.
8. Rathbone M. J, Ponchel G, Ghazali F. A, Systemic oral mucosal drug delivery and delivery systems. In: Rathbone M. J., ed. Oral Mucosal Drug Delivery. Marcel Dekker, New York, 1996, PP 241-284.
9. Amir H. Shojaei, buccal mucosa as a route for systemic drug delivery: A review, J Pharm Pharm Sci., 1, 1998, PP 15-30.
10. Aungst B. J, Oral mucosal permeation enhancement. In: Rathbone M. J., ed. Oral mucosal drug delivery. Marcel Dekker, New York, 1996, PP 65-83.
11. Squier C. A, Johnson N. W, Hopps R. M, Human Oral mucosa: Development, structure and function. Blackwell Scientific Publications, Oxford, New York 1976, PP 7-44.
12. Patel V. F, Liu F, Brown M. B, Advances in oral transmucosal drug delivery, J Control Release., 153, 2011, PP 106-116.
13. Zhang H, Zhang J, Streisand J. B, Oral mucosal drug delivery: Clinical pharmacokinetics and therapeutic applications, Clin Pharmacokinet., 4, 2002, PP 661-680.
14. Veuillez F, Kalia Y. N, Jacques Y, Deshusses J, Buri P, Factors and strategies for improving buccal absorption of peptides, Eur J Pharm Biopharm., 51, 2001, PP 93-109.
15. Hao J, Heng P. W, Buccal delivery systems, Drug Dev Ind Pharm., 29, 2003, PP 821-832.
16. Alur H. H, Johnston T. P, Mitra A. K, Encyclopedia of pharmaceutical technology, Marcel Dekker, New York, 2001, PP 193-218.
17. Schenkels L. C. P. M, Gururaja T. L, Levine M. J, Salivary mucins: Their role in oral mucosal barrier functions and drug delivery. In: Rathbone M. J., ed. Oral mucosal drug delivery. Marcel Dekker, New York, 1996, PP 197-239.
18. Amir H Shojaei, Buccal mucosa as a route for systemic drug delivery: A review, J Pharm Pharm Sci., 1, 1998, PP 15-30.
19. Connor J. and Huang L. Acid induced fusion of liposomes. In: Sowers A. E. ed. Cell fusion. Plenum Publishing Corporation, New York, 1988, PP 285-299.
20. Grinnel F, Cellular adhesiveness and extracellular substrata, Int Rev Cytol., 53, 1978, PP 65-144.
21. Edwards J. G, The biochemistry of cell- adhesion, Prog Surf Sci., 13, 1987, 125-196.
22. A. C. Taylor. Adhesion of cells to surfaces, In: Manley, R. S., ed. Adhesion in biological systems, Academic Press, New York, 1970, PP 45-51.
23. Liptova, T. E., Medical polymer adhesives, Adv Polym Sci., 79, 1986, 67-93.
24. Kamath K. R. and Park K, Mucosal adhesive preparations. In: Swarbrick J. and Boylan J. C., ed. Encyclopaedia of pharmaceutical technology, Marcel Dekker, New York, 1994, PP 133-163.
25. Chen S. Y, Squier C. A, The ultra structure of the oral epithelium. In: Squier C. A. and Gerson S. J., ed. The structure and function of oral mucosa. Pergamon, Oxford, New York 1984, PP 7-30.
26. Smart J. D, The role of water movement and polymer hydration in mucoadhesion. In: Mathiowitz E, Chickering D. E, Lehr M., ed. Bioadhesive drug delivery systems: Fundamentals, novel approaches and development. Marcel Dekker, New York, 1996, PP 11-23.
27. Duchene D, Touchard F, Peppas N, Pharmaceutical and medical aspects of bioadhesive systems for drug administration, Drug Dev Ind Pharm., 14, 1988, PP 283-318.
28. Madhav NVS, Ojha A, Tyagi Y, Negi M Mucoadhesion: a novelistic platform for drug delivery system. Int J Pharm, 2014; 2: 246-258.
29. Giradkar KP et al, Design development and in vitro evaluation of bioadhesive dosage form for buccal route, International Journal of Pharma Research and Development, 2010; 2: 17. 24.
30. Shaikh S, Shaikh Z, Khan GJ, Patel MS. A Review on buccal mucoadhesive drug delivery system. European Journal of Pharmaceutical and Medical Research. 2017;4(11):247-252.
31. Santanu R, Rajesh G, Sourav S, A Review on Buccal Mucoadhesive Drug Delivery Systems. Indo-Global Journal of Pharmaceutical Sciences. 2011, Vol 1., Issue 3: Page No. 223-233.
32. M. Jug, Becireviclacan, Influence of hydroxypropyl-betacyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur. J. Pharm. Sci., 2004, 21:251-260. 22.
33. G. Ikinici, S. Senel, et al. Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation, Int. J. Pharm., 2004, 277: 173-178. 23.
34. A. M. Mumtaz, H. S. Chang, Design of a dissolution apparetus suitable for in situ release study of triamcinolone acetonide from bioadhesive buccal tablets. Int. J. Pharm., 1995, 121: 129-139.
35. Garry LM, Samuel DH, Bill JB, Arlie BB, Pradeep S, Madhusudhan H. Sublingual and buccal fim composition. US20110033542A1, 2011.
36. Stephen M, Greg S, Christopher EF, Orally administrable films. US20100063110A1, 2010.
37. Stephen M, Greg S, Christopher EF, Nicole O, Multi - zone films. US20100266669A1, 2010.
38. Meir H, Throdis K, Skuli S, Orally administrable films and preparation thereof. US8840935B2, 2014.
39. Richard TC, Maurice ED, Oral/Buccal transmucosal delivery methods for electrolyte compositions including xylitol. US20080152695A1, 2008.
40. James EB, Film bandage for mucosal administration of actives. US20070172515A1, 2007.
41. Richard CF, Two Phase mucoadhesive composition. US20070298087A1, 2007.
42. Joachim M, Klaus O, Hans-Rainer H, Oral formulations of desoxypeganine and thereof. US20070155774A1, 2006.
43. Tina R, Christian VF, Transmucosal form of Administration with Reduced Mucosal Irritation. WO2005000263A1, 2005.
44. Kenneth W, Warren H, Kay O, Transmucosal Delivery of Proton Pump Inhibitors. US20040006111A1, 2004.
45. Horst GZ, Jian-Hwa G, Anthony S, Water soluble film for oral administration with instant wettability. US20020127190A1, 2002.
46. Michael AR, Staci LR, James WM, Bio adhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation and thereof. US6375963B1, 2002.
47. S. Indiran Pather, Michael J. Rathbone and Sevda Senel, Current status and the future of buccal drug delivery systems, Expert Opin Drug Deliv., 5, 2008, PP 531-542.